Modeling Fe II Emission and Revised Fe II (UV) Empirical Templates for the Seyfert 1 Galaxy I Zw 1 von Bruhweiler, F, Verner, E

Volltext

CLOUDY 90: Numerical Simulation of Plasmas and Their Spectra von Ferland, G. J., Korista, K. T., Verner, D. A., Ferguson, J. W., Kingdon, J. B., Verner, E. M.

Volltext

A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas von Balasubramanian, S, Ramos, J, Luo, W, Sirisawad, M, Verner, E, Buggy, J J

Volltext

The Binarity of η Carinae Revealed from Photoionization Modeling of the Spectral Variability of the Weigelt Blobs B and D von Verner, E, Bruhweiler, F, Gull, T

Volltext

Final analysis of Australasian Leukaemia & Lymphoma Group NHL29: A phase II study of ibrutinib, rituximab and mini‐CHOP in very elderly patients with newly diagnosed DLBCL von Verner, E., Johnston, A., Pati, N., Hawkes, E., Lee, H. P., Cochrane, T., Cheah, C. Y., Filshie, R., Purtill, D., Sia, H., Enjeti, A. K., Brown, C., Murphy, N., Curnow, J., Lee, K., Gandhi, M. K., Butcher, B. E., Trotman, J.

Volltext

PRELIMINARY SAFETY DATA FROM PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL MALIGNANCIES TREATED WITH THE NOVEL B‐CELL LYMPHOMA 2 (BCL2) INHIBITOR BGB‐11417 von Cheah, C. Y., Verner, E., Tam, C. S., Hilger, J., Gao, Y., Huang, J., Simpson, D., Opat, S.

Volltext

Glofitamab plus R‐CHOP or polatuzumab vedotin‐R‐CHP is deliverable with high overall response in patients ≤65 years of age with high‐risk DLBCL: Interim analysis of COALITION... von Minson, A., Verner, E., Giri, P., Wong, S. M., Ratnasingam, S., Butler, J., Janowski, W., Ku, M., Cheah, C. Y., Hertzberg, M., Herbert, K., Hamad, N., Yannakou, C. K., Neeson, P., Saghebi, J., Blombery, P., Robertson, M., Lau, L. S., Xie, J., Seymour, J. F., Dickinson, M.

Volltext

ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY von Shadman, M., Munir, T., Roback, T., Brown, J. R., Kahl, B. S., Ghia, P., Giannopoulos, K., Šimkovič, M., Österborg, A., Laurenti, L., Walker, P., Opat, S., Ciepluch, H., Greil, R., Hanna, M., Tani, M., Trněný, M., Brander, D., Flinn, I. W., Grosicki, S., Verner, E., Tedeschi, A., De Guibert, S., Tumyan, G., Laribi, K., García, J. A., Li, J., Tian, T., Ramakrishnan, V., Liu, Y., Szeto, A., Paik, J., Cohen, A., Tam, C. S., Jurczak, W.

Volltext

P687: A PHASE 1 STUDY WITH THE NOVEL B‐CELL LYMPHOMA 2 (BCL2) INHIBITOR BGB‐11417 AS MONOTHERAPY OR IN COMBINATION WITH ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH B‐CELL MALIGNANCI... von Opat, S., Cheah, C. Y., Lasica, M., Verner, E., Browett, P. J., Chan, H., Soumerai, J. D., González Barca, E., Hilger, J., Fang, Y., Huang, J., Simpson, D., Tam, C. S.

Volltext

Numerical Simulations of Fe II Emission Spectra von Verner, E. M, Verner, D. A, Korista, K. T, Ferguson, J. W, Hamann, F, Ferland, G. J

Volltext

Revisited Abundance Diagnostics in Quasars: Fe II/Mg II Ratios von Verner, E, Bruhweiler, F, Verner, D, Johansson, S, Gull, T

Volltext

483 Irreversible covalent pan-FGFR inhibitors are highly efficacious against FGFR-dependent cancers von Phan, V.T, Verner, E, Gerritsen, M, Bradshaw, J.M, Goldstein, D.M, Hill, R.J, Karr, D, LaStant, J, Nunn, P, Tam, D, Shu, J, Funk, J.O, Brameld, K

Volltext

Fe II Diagnostic Tools for Quasars von Verner, E, Bruhweiler, F, Verner, D, Johansson, S, Kallman, T, Gull, T

Volltext

BRUTON'S TYROSINE KINASE (BTK) INHIBITOR BGB‐3111 DEMONSTRATES HIGH VERY GOOD PARTIAL RESPONSE (VGPR) RATE IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) von Trotman, J., Opat, S., Marlton, P., Gottlieb, D., Simpson, D., Cull, G., Ritchie, D., Verner, E., Ratnasingam, S., Anderson, M., Wood, P., Wang, L., Xue, L., Hedrick, E., Huang, J., Hilger, J., Seymour, J.F., Roberts, A.W., Tam, C.S.

Volltext

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial von Tam, Constantine S, Brown, Jennifer R, Kahl, Brad S, Ghia, Paolo, Giannopoulos, Krzysztof, Jurczak, Wojciech, Šimkovič, Martin, Shadman, Mazyar, Österborg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Chan, Henry, Ciepluch, Hanna, Greil, Richard, Tani, Monica, Trněný, Marek, Brander, Danielle M, Flinn, Ian W, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, Li, Jianyong, Tian, Tian, Zhou, Lei, Marimpietri, Carol, Paik, Jason C, Cohen, Aileen, Huang, Jane, Robak, Tadeusz, Hillmen, Peter

Volltext

Zanubrutinib monotherapy for patients with treatment-naive chronic lymphocytic leukemia and 17p deletion von Tam, Constantine S., Robak, Tadeusz, Ghia, Paolo, Kahl, Brad S., Walker, Patricia, Janowski, Wojciech, Simpson, David, Shadman, Mazyar, Ganly, Peter S., Laurenti, Luca, Opat, Stephen, Tani, Monica, Ciepluch, Hanna, Verner, Emma, Simkovi, Martin, Osterborg, Anders, Trneny, Marek, Tedeschi, Alessandra, Paik, Jason C., Kuwahara, Sowmya B., Feng, Shibao, Ramakrishnan, Vanitha, Cohen, Aileen, Huang, Jane, Hillmen, Peter, Brown, Jennifer R.

Volltext

Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode:  Inhibitors of Urokinase-Type Plasminogen Activator and Factor Xa von Verner, Erik, Katz, Bradley A, Spencer, Jeffrey R, Allen, Darin, Hataye, Jason, Hruzewicz, Witold, Hui, Hon C, Kolesnikov, Aleksandr, Li, Yong, Luong, Christine, Martelli, Arnold, Radika, Kesavan, Rai, Roopa, She, Miles, Shrader, William, Sprengeler, Paul A, Trapp, Sean, Wang, Jing, Young, Wendy B, Mackman, Richard L

Volltext

High-Resolution Spectroscopy of Faint Emission Lines in the Orion Nebula von Baldwin,, J. A, Verner,, E. M, Verner,, D. A, Ferland,, G. J, Martin,, P. G, Korista,, K. T, Rubin, R. H

Volltext

Atomic Data for Permitted Resonance Lines of Atoms and Ions from H to Si, and S, Ar, Ca, and Fe von Verner, D.A., Verner, E.M., Ferland, G.J.

Volltext

Continuum Pumping of [Fe II] in the Orion Nebula von Verner, E. M, Verner, D. A, Baldwin, J. A, Ferland, G. J, Martin, P. G

Volltext